Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

NCT01137162 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01137162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01137162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors
Lead sponsor
Stanford University
Phase
Observational
Overall status
Terminated
Start date
August 31, 2008
Completion date
October 31, 2011
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal, colon, and rectal cancers, colon cancer, colon/rectal cancer, colon/rectal cancer anal cancer, colon/rectal cancer colon cancer, colon/rectal cancer rectal cancer, colonic neoplasms, colorectal neoplasms, head and neck cancer, head and neck cancers, head and neck cancers hypopharynx, head and neck cancers larynx, head and neck cancers lip, head and neck cancers nasopharynx, head and neck cancers oral cavity, head and neck cancers oropharynx, head and neck cancers trachea, lung cancer, lung cancer non-small cell cancer (nsclc), lung cancer small cell lung cancer (sclc)